The Clinical Features and Prognostic Factors of 104 Cases of Nasal Natural Killer/T-Cell Lymphoma
Q. Guo,F. Wu,X. Liu,C. Fan,C. Li,Y. Zhang,D. Liu,Q. Lei,Y. Xie,Y. Wang
DOI: https://doi.org/10.1016/j.ijrobp.2019.06.1451
2019-01-01
Abstract:To explore the clinical features and influencing factors of patients with nasal NK/T-cell lymphoma. We retrospectively analyzed clinical data of 104 patients with nasal NK/T-cell lymphoma treated by radiotherapy from January 2010 to December 2017. The survival rate was calculated by univariate analyses using Kaplan-Meier methods and Log-rank test. Moreover, a multivariate analysis was carried out using Cox proportional hazards model. Among the 104 patients composed of 77 males and 27 females, 16 (15.4%) were older than 60 years old, 29 (27.9%) had B symptoms, and 88 (84.6%) had ECOG less than 2 score. As classified by Ann Arbor staging system , 80 cases (76.9%) were in 1-2 stages and 24 cases (23.1%) were in 3-4 stages. 74 patients (71.2%) had primary sites in nasal cavities, 26 patients (25.0%) had peripheral tissue invasion. 36 patients (34.6%) had increased LDH. For the first treatments, 15 patients (14.4%) chose radiotherapy and 82 patients (78.8%) chose chemotherapy. Of the 68 patients who underwent radiotherapy (65.4%), 22.1% chose 3D-CRT (23 cases), 36.5% used IMRT (38 cases), 1% patients chose TOMO (1 cases) and 5.8% patients used therapies that were unspecific(6 cases). 34.6% patients did not receive radiotherapy during treatment. Among patients with radiotherapy, 85.9% of patients received more than 50Gy as total radiation dose (55 cases), 14.1% patients received less than 50Gy radiation dose (9 cases). After the first treatment and the initial-course therapy, 64.4% of patients had complete and partial response to the treatment (67 cases), 29.8% patients were with stable disease or progression disease (31 cases), and 6 patients were unable to be evaluated for efficacy (5.8%). Five years overall survival was 47% in the whole group. Risk factors in univariate analyses included LDH, Ann Arbor staging, IPI score, initial curative effect, radiotherapy dose and technology, ECOG score, Independent risk factors in multivariable analyses included initial curative effect and Ann Arbor staging. Five years progression-free survival was 51.2%. Risk factors in univariate analyses included Ann Arbor staging, IPI score, initial curative effect, site of cancer, radiotherapy dose, and technology; Independent risk factors in multivariable analyses included Ann Arbor staging and initial curative effect. The five years overall survival and progression-free survival of nasal NK/T-cell lymphoma were 47% and 51.2% respectively. The multivariable factor analysis had suggested Ann Arbor staging and the initial curative effect were the independent risk factors.